Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153386 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine
A Phase 1 study, sponsored by United Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01153386 is a Phase 1 study that has completed, run by United Therapeutics. The registered enrollment target is 36 participants.
The verdict
NCT01153386, a Phase 1 study, has completed, sponsored by United Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study will compare the bioavailability and pharmacokinetics of the 0.5 mg, 1 mg and 2.5 mg treprostinil diethanolamine tablet strengths in healthy volunteers.
Interventions
- DRUG Treprostinil diethanolamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-07 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153386
The ClinicalTrials.gov registry entry for NCT01153386 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United Therapeutics, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treprostinil diethanolamine is the first listed.
NCT01153386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01153386 about?
NCT01153386 is a clinical study titled "Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine". This study will compare the bioavailability and pharmacokinetics of the 0.5 mg, 1 mg and 2.5 mg treprostinil diethanolamine tablet strengths in healthy volunteers.
What is the current status of trial NCT01153386?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2010-07. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01153386?
The interventions under investigation include: Treprostinil diethanolamine (DRUG).
Who is sponsoring clinical trial NCT01153386?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.